Stringent Nationwide Selection Criteria for CAR-T Cell Therapy Ensure Favourable Outcome of Patients with LBCL - First Data from the Austrian CAR-T NetworkJakob Rudzki, Philipp Wohlfarth, Richard Greil et al.|Blood|2022Cited by 1
Austrian Real-world Experience With Standard of Care Brexucabtagene Autoleucel in Patients With Relapsed or Refractory Mantle-Cell LymphomaStefan Koeck, Thomas Melchardt, Natalia Rotter et al.|Transplantation and Cellular Therapy|2026Cited by 1